June brought genitourinary cancer updates, and CURE is sharing the latest in kidney cancer treatment, as well as FDA ...

At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of ...

I share how hope, even when uncertain, helped me through cancer and honors its role in balancing realism, resilience and ...

Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data ...

An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as ...

I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and ...

I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who ...

Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.

Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore ...